Orthofix International | OFIX - Operating Expenses


Orthofix International reported $10.89M in Operating Expenses for its fiscal quarter ending in September of 2024.





Operating Expenses Change Date
Accuray USD 37.18M 567K Dec/2024
AngioDynamics USD 81.98M 1.96M Feb/2025
Artivion USD 56.62M 195K Sep/2024
AtriCure USD 138.01M 3.95M Dec/2025
Dexcom USD 936.6M 30.2M Dec/2025
EDAP TMS EUR 18.8M 3.01M Sep/2025
Globus Medical USD 645.11M 241.46M Dec/2025
Hologic USD 349.4M 447.1M Dec/2025
Inogen USD 49.14M 665K Sep/2024
Insulet USD 637.5M 48.9M Dec/2025
Integra LifeSciences USD 368.92M 668.65M Dec/2025
J&J USD 18.97B 2.38B Dec/2025
Medtronic USD 7.28B 16M Dec/2025
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Orthofix International USD 10.89M 209.57M Sep/2024
Smith & Nephew USD 2.52B 84M Dec/2025
STAAR Surgical USD 68.74M 1.55M Dec/2025
Stryker USD 5.2B 505M Dec/2025
Surmodics USD -245.35M 363.49M Sep/2024
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 532.64M 3.29B Dec/2025
Veracyte USD 116M 7.24M Dec/2025
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025